Bleeding Disorders
From the Journals
More exercise for people with hemophilia, experts advise
Physical activity can improve “quality of life” in people with hemophilia.
From the Journals
Women with von Willebrand disease: Managing menstrual and postpartum bleeding
One of three reviews to develop guidelines shows a potential role for postpartum tranexamic acid.
From the Journals
Post–COVID vaccine AHA cases raise eyebrows in Italy
Four cases of acquired hemophilia A that occurred following COVID-19 vaccinations in one Italian province could indicate “possible complications...
From the Journals
Gene therapy: A ‘one and done’ hemophilia B treatment?
Phase 3 study of a one-time gene therapy shot enabled almost all hemophilia B patients to end full-dose bleeding prophylaxis.
Conference Coverage
New hemophilia treatments: ‘Our cup runneth over’
A range of new options is emerging to treat hemophilia patients.
From the Journals
Endometriosis not linked with preterm birth, new study finds
Changing monitoring strategies to prevent preterm birth for women with the disease may not be necessary.
Latest News
Aspirin use risk for postpartum bleeding unclear
Demographic and clinical factors likely accounted for more of the bleeding risk observed than the low-dose aspirin did, but time of...
Conference Coverage
Fitusiran: Great ‘leap forward’ in hemophilia treatment
Cost will be a major consideration if fitusiran is approved for the U.S. market.
News
FDA approves new interferon for polycythemia vera
A longer half-life means dosing every 2 weeks, instead of weekly.
From the Journals
Data from Spain yield new insights on a rare hemophilia
Findings show high rates of antithrombotic use before diagnosis and fatal infections after immunosuppressive therapy starts.
From the Journals
Rivaroxaban’s single daily dose may lead to higher bleeding risk than other DOACs
Corroborating previous studies, Iceland researchers report that rivaroxaban poses the highest risk of GI bleeding, compared with other DOACs.